Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (Q35017874)

5 August 2017

1 reference

title

Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (English)

1 reference

5 August 2017

0 references

Shinsaku Imashuku

1

1 reference

5 August 2017

1 December 2002

1 reference

Critical Reviews in Oncology Hematology

5 August 2017

1 reference

5 August 2017

44

1 reference

5 August 2017

3

1 reference

5 August 2017

259-272

1 reference

Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Virus-associated hemophagocytic syndrome: identification of an immunoproliferative precursor lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Fatal epstein-barr virus-associated hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Fulminant course of infectious mononucleosis with virus-associated hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Chronic active Epstein-Barr virus infection in children in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

EBV-elicited familial hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Clonal change of infiltrating T-cells in children with familial hemophagocytic lymphohistiocytosis: possible association with Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Large deletion of the X-linked lymphoproliferative disease gene detected by fluorescence in situ hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Treatment strategies for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Haemophagocytic lymphohistiocytosis in association with granular lymphocyte proliferative disorders in early childhood: characteristic bone marrow morphology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

False-positive IgM antibody tests for cytomegalovirus in patients with acute Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Acute Viral Encephalitis in Adults?a Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Immunologic dysregulation in a patient with familial hemophagocytic lymphohistiocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Heterogeneity of immune markers in hemophagocytic lymphohistiocytosis: comparative study of 9 familial and 14 familial inheritance-unproved cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Further evidence for genetic heterogeneity in familial hemophagocytic lymphohistiocytosis (FHLH).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Latent Epstein-Barr virus infection is frequently detected in subcutaneous lymphoma associated with hemophagocytosis but not in nonfatal cytophagic histiocytic panniculitis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Systemic hemophagocytosis masking the diagnosis of large cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Abdominal ultrasound findings in children with hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Serum and urine beta-2-microglobulin in hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Elevation of soluble Fas and soluble Fas ligand in reactive macrophage activation syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Fas ligand-induced apoptosis of hepatocytes in natural killer cell leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Soluble granzymes are released during human endotoxemia and in patients with severe infection due to gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Monitoring of Epstein-Barr virus serology in children after liver transplant: lack of clinical correlation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Epstein-Barr virus induced virus-associated hemophagocytic syndrome and monoclonal TCR-beta rearrangement: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Hemophagocytic syndrome associated with aggressive natural killer cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Outcome of clonal hemophagocytic lymphohistiocytosis: analysis of 32 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Virus-associated hemophagocytic syndrome due to epstein-barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Splenectomy in haemophagocytic lymphohistiocytosis: report of histopathological changes with CD19+ B-cell depletion and therapeutic results.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Recent developments in the management of haemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two case reports

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Effect of plasma exchange on refractory hemophagocytic syndrome complicated with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Treatment of familial erythrophagocytic lymphohistiocytosis with cyclosporine A.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Dramatic efficacy of antithymocyte globulins in childhood EBV-associated haemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Treatment of ulcerative colitis with camostat mesilate, a serine protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Two patients with severe alcoholic hepatitis accompanied by hypercytokinemia and granulocytic hyperelastasemia, successfully treated by intravenous infusion of urinastarine (Miraclid).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Therapeutic rationale for antithrombin III in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Severe chronic active Epstein-Barr virus infection accompanied by virus-associated hemophagocytic syndrome, cerebellar ataxia and encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Calcification in the basal ganglia with chronic active Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Evidence for a hybrid macrophage phenotype in erythrophagocytic histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Haemophagocytic syndrome treated with cyclosporin A: a T cell disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocytic leukaemia and chronic natural killer cell lymphocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

The use of cyclosporin-A in the treatment of virus-associated hemophagocytic syndrome in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Management of severe neutropenia with cyclosporin during initial treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Chronic T-cell lymphocytosis with neutropenia. Its association with Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Acute agranulocytosis following infectious mononucleosis. Report of a case.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Infectious mononucleosis. Death due to agranulocytosis and pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Acute leucoencephalopathy during cyclosporin A therapy in a patient with nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Correction of Duncan's syndrome by allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Bone marrow transplantation during fulminant EBV-infection in Duncan's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Fatal cytomegalovirus interstitial pneumonia following autologous peripheral blood stem cell transplantation. Fukuoka Bone Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900117-8

7 January 2021

10.1016/S1040-8428(02)00117-8

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12467966